Innovation has been central to America’s economic success since the nation’s founding. In a new column for RealClearMarkets, Market Institute President Charles Sauer argues that policymakers should remember the vital role patents have played in driving growth, investment, and technological advancement.
Sauer traces the history of patents from the earliest days of the Republic, noting that intellectual property protections were considered so important that they were specifically included in the Constitution. Those protections helped encourage breakthroughs that expanded infrastructure, increased trade, and fueled economic growth.
“Innovation has driven America for the last 250 years. In fact, patents were the only ‘right’ provided for in the original Constitution.”
The article also examines the long history of patent disputes, from the sewing machine wars of the 19th century to today’s debates over pharmaceutical innovation. While competitors and policymakers often criticize patent holders for profiting from their inventions, Sauer argues that exclusive rights are precisely what incentivize costly research and development investments.
“It is tough seeing your competitor come up with an idea, which they are then able to exclusively profit from for the next 20 years. However, this is the incentive that drives firms to invest in research and development, which then leads to even more ideas.”
Sauer pays particular attention to the pharmaceutical industry, where developing a new medicine can cost billions of dollars and require years of regulatory review. Rather than targeting patents, he argues policymakers should focus on reducing regulatory barriers that delay innovation and increase costs.
“If a drug had twice the time on the market under patent protection, companies could charge half the price while generating the same profits.”
Instead, Congress continues to scrutinize pharmaceutical patents and consider policies such as price controls that risk undermining future innovation. Sauer contends that lawmakers are focusing on the wrong target.
“Congress is getting in the way – like a thorny thicket. They are impeding innovation.”
As Congress examines the future of intellectual property policy and pharmaceutical access, Sauer concludes that strong patent protections remain essential to both economic growth and medical breakthroughs.
“As our nation’s forefathers understood, Congress should support innovation as the way to grow our country.”
Read Charles Sauer’s full RealClearMarkets column to learn why protecting innovation—not weakening patents—remains critical to America’s economic and technological leadership.
0 Comments